[go: up one dir, main page]

NO20065297L - Use of GPCR54 ligands to treat infertility - Google Patents

Use of GPCR54 ligands to treat infertility

Info

Publication number
NO20065297L
NO20065297L NO20065297A NO20065297A NO20065297L NO 20065297 L NO20065297 L NO 20065297L NO 20065297 A NO20065297 A NO 20065297A NO 20065297 A NO20065297 A NO 20065297A NO 20065297 L NO20065297 L NO 20065297L
Authority
NO
Norway
Prior art keywords
gpcr54
ligands
treat infertility
infertility
treat
Prior art date
Application number
NO20065297A
Other languages
Norwegian (no)
Inventor
Robert K Campbell
Xuliang Jiang
Shoji Nagatani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20065297L publication Critical patent/NO20065297L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelsen er rettet mot fremgangsmåter og sammensetninger for behandlingen av infertilitet.The present invention is directed to methods and compositions for the treatment of infertility.

NO20065297A 2004-04-23 2006-11-17 Use of GPCR54 ligands to treat infertility NO20065297L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56475604P 2004-04-23 2004-04-23
PCT/US2005/013339 WO2005117939A2 (en) 2004-04-23 2005-04-19 Use of gpcr54 ligands for the treatment of infertility

Publications (1)

Publication Number Publication Date
NO20065297L true NO20065297L (en) 2006-11-17

Family

ID=35463344

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065297A NO20065297L (en) 2004-04-23 2006-11-17 Use of GPCR54 ligands to treat infertility

Country Status (7)

Country Link
EP (1) EP1750513A4 (en)
JP (1) JP2007533748A (en)
AU (1) AU2005249373A1 (en)
CA (1) CA2562676A1 (en)
IL (1) IL178795A0 (en)
NO (1) NO20065297L (en)
WO (1) WO2005117939A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005257484A1 (en) 2004-06-25 2006-01-05 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (en) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co Metastin Derivatives And Use Thereof
CA2698745A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent
GB0719592D0 (en) 2007-10-08 2007-11-14 Medical Res Council Compound, use and method
US20110212890A1 (en) * 2008-07-30 2011-09-01 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
EP2340047A1 (en) * 2008-09-19 2011-07-06 Nektar Therapeutics Polymer conjugates of kiss1 peptides
CA2737040C (en) 2008-09-19 2017-05-02 Nektar Therapeutics Polymer conjugates of therapeutic peptides
WO2013017631A1 (en) 2011-08-04 2013-02-07 Msd Oss B.V. Kisspeptide-pentasaccharide conjugates
US20150087610A1 (en) * 2012-03-20 2015-03-26 Monell Chemcial Senses Center Method of Modifying Fertility
FR3001455B1 (en) 2013-01-31 2017-10-06 Agronomique Inst Nat Rech AGONIST COMPOUNDS OF THE KISS1R RECEPTOR AND THEIR USE IN INDUCING OVULATION IN MAMMALS
TW201605907A (en) * 2014-08-12 2016-02-16 國立臺灣大學 Use of a short-chain peptide capable of controlling spermatozoa fertilization performance to increasing success rates of in vitro fertilization
IL311335A (en) * 2016-09-30 2024-05-01 Sumitomo Pharma Switzerland Gmbh Methods of treating female infertility
CN109125307B (en) * 2018-09-03 2021-05-07 河南牧翔动物药业有限公司 Clomidinol-polypeptide compound, pharmaceutical preparation, and preparation methods and applications thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050090420A (en) * 2002-12-26 2005-09-13 다케다 야쿠힌 고교 가부시키가이샤 Metastin derivative and use thereof
EP1604682A4 (en) * 2003-03-12 2009-06-24 Takeda Chemical Industries Ltd Gonadal function improving agents

Also Published As

Publication number Publication date
WO2005117939A2 (en) 2005-12-15
AU2005249373A1 (en) 2005-12-15
WO2005117939A3 (en) 2006-06-01
CA2562676A1 (en) 2005-12-15
EP1750513A2 (en) 2007-02-14
IL178795A0 (en) 2007-03-08
JP2007533748A (en) 2007-11-22
EP1750513A4 (en) 2009-07-22
WO2005117939A9 (en) 2006-04-20

Similar Documents

Publication Publication Date Title
NO20065297L (en) Use of GPCR54 ligands to treat infertility
NO20092637L (en) Methods of treatment
EA200700175A1 (en) COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY DISEASES
DE602005026508D1 (en) MONOCYCLIC HETEROCYCLES AS KINASE-HEMMER
EA200700851A1 (en) OBTAINING AND APPLICATION OF BIPHENYL-4-ILKARBONYLAMINO ACID DERIVATIVES FOR TREATMENT OF OBESITY
ATE464323T1 (en) COMPOSITIONS AND METHODS FOR TUMOR DIAGNOSIS AND TREATMENT
MX2007011545A (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors.
NO20064325L (en) Heteroberlaminopyrazole derivatives useful for the treatment of diabetes
NO20065859L (en) Use of IL-17 treatment for fertility-related disorders
TW200510334A (en) Preraration and use of aryl alkyl acid derivatives for the treatment of obesity
NO20083002L (en) Method for using CD40 binding compounds
EA201000895A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES
CY1109741T1 (en) SNS-595 AND METHODS OF USE thereof
EA201070247A1 (en) PROTEAS INHIBITORS
TW200716546A (en) Oxindole compounds and their uses as therapeutic agents
EA200900802A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
NO20065251L (en) Use of peptidic compounds for prophylaxis and treatment of chronic headaches
EA200600078A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOID DISEASES
DE602005009748D1 (en) 3-PHENYL-PYRAZOL DERIVATIVES AS MODULATORS OF THE BENEFICIAL SOURCES OF TREATING 5-HT-2A-SEROTONINE RECEPTOR
NO20073776L (en) Tricyclic delta opioid modulators
NO20075764L (en) Combined use of prostaglandin compound and proton pump inhibitor to treat gastrointestinal disorders
ATE445644T1 (en) APPLICATION OF MOLECULES AND METHODS TO TREAT MCP-1/CCR2 ASSOCIATED DISEASES
DE602005012481D1 (en) 2,7-SUBSTITUTED 5-AMINO-4-HYDROXY-8- (1H-INDOL-5-YL) -OCTANAMIDE DERIVATIVES AS RENIN INHIBITORS FOR THE TREATMENT OF BLOOD HIGH PRESSURE
DE60220385D1 (en) BENZIMIDAZOLE FOR THE TREATMENT OF SEXUAL MALFUNCTIONS
NO20093536L (en) Combination cancer therapy including vinflunine and trastuzumab

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

FC2A Withdrawal, rejection or dismissal of laid open patent application